KATHERINE MCCRADY: Open Payments
NPI 1023452174 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,522 in 110 payments from 13 companies in 2025. Trend: 2023 $1,395 · 2024 $2,419 · 2025 $2,522
Food & beverage: $2,187Education: $335
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 19 | $566 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $565 |
| UCB, Inc. | 21 | $360 |
| ABBVIE INC. | 12 | $212 |
| Janssen Biotech, Inc. | 14 | $169 |
| LEO Pharma Inc. | 10 | $157 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| GENZYME CORPORATION | 4 | $102 |
| Eli Lilly and Company | 1 | $99 |
| PFIZER INC. | 3 | $53 |
Products named: Bimzelx, EBGLYSS, ILUMYA, TALTZ, SKYRIZI, TREMFYA, DUPIXENT, COSENTYX.
Industry payments across AR — which companies pay providers there.
